Hematoloxía

2003

1. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: No differences in cytogenetic responses

   Annals of Hematology, Vol. 82, Núm. 12, pp. 750-758

2. Acute myeloid leukemia with MLL rearrangements: Clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells

   Leukemia, Vol. 17, Núm. 1, pp. 76-82

3. Anticoagulación oral

   Anales de medicina interna, Vol. 20, Núm. 7, pp. 377-384

4. Anticoagulación oral

   Anales de Medicina Interna, Vol. 20, Núm. 7, pp. 377-384

5. Caso clínico: Síndrome mielodisplásico secundario a tratamiento de leucemia promielocítica aguda

   Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 6, Núm. 2, pp. 121-128

6. Exantema generalizado granulomatoso durante un tratamiento con factor estimulante de colonias de granulocitos

   Actas Dermo-Sifiliograficas, Vol. 94, Núm. 6, pp. 402-405

7. High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: The GEL-TAMO experience

   Annals of Oncology, Vol. 14, Núm. 12, pp. 1768-1775

8. High-dose therapy in diffuse large cell lymphoma: Results and prognostic factors in 452 patients from the GEL-TAMO Spanish cooperative group

   Annals of Oncology, Vol. 14, Núm. 1, pp. 140-151

9. Hydroxyurea-induced skin ulcerations in patients with chronic myeloproliferative disorders

   Journal of Hematotherapy and Stem Cell Research

10. Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication

    Haematologica, Vol. 88, Núm. 6, pp. 637-645

11. Incidence and characteristics of myelodysplastic syndromes in Ourense (Spain) between 1994-1998

    Haematologica, Vol. 88, Núm. 10, pp. 1197-1199

12. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation

    Blood, Vol. 102, Núm. 1, pp. 394-403

13. Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry

    Bone Marrow Transplantation, Vol. 32, Núm. 10, pp. 987-992

14. Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

    Experimental Hematology